| 51 |
17287424 | Regulatory T cells and T cell depletion: role of immunosuppressive drugs. | 2007 Mar |
1 |
| 52 |
17453966 | Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. | 2007 |
2 |
| 53 |
17996694 | Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. | 2007 Dec 15 |
1 |
| 54 |
18021968 | The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. | 2007 Nov |
8 |
| 55 |
20477665 | The different effects of cyclosporin A and rapamycin on regulatory CD4+CD25+ T cells: potential relationship with transplant tolerance induction. | 2007 May |
1 |
| 56 |
16210336 | Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. | 2006 Feb 1 |
3 |
| 57 |
16461044 | Comparison between sirolimus- and paclitaxel-eluting stent in T-cell subsets redistribution. | 2006 Feb 15 |
1 |
| 58 |
16477233 | Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells. | 2006 Feb 15 |
1 |
| 59 |
16778294 | Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate. | 2006 Jun |
1 |
| 60 |
17142730 | Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. | 2006 Dec 15 |
4 |
| 61 |
15707399 | Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro. | 2005 Mar |
1 |
| 62 |
16237064 | Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. | 2005 Nov 1 |
1 |
| 63 |
12176409 | Rapamycin blocks the generation of regulatory T cells facilitated by posttransplant infusion of donor T cells through increasing the apoptosis of thymic CD4(+)CD25(+) cells. | 2002 Aug |
1 |
| 64 |
8286755 | Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow. | 1994 Jan 15 |
1 |